Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohammad Almehanna"'
Autor:
Sondas Alsharidah, Mariam Ayed, Reem M. Ameen, Fatma Alhuraish, Najat A. Rouheldeen, Farah R. Alshammari, Alia Embaireeg, Mariam Almelahi, Maitham Adel, Mohammed E. Dawoud, Mohammad A. Aljasmi, Nashmi Alshammari, Abdullah Alsaeedi, Wasel Al-Adsani, Hussan Arian, Husain Awad, Humoud A. Alenezi, Azeez Alzafiri, Enas F. Gouda, Mohammad Almehanna, Salem Alqahtani, Abdulrahman Alshammari, Medhat Z. Askar
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 439-446 (2021)
Objective: To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for patients with moderate and severe COVID-19 disease. Methods: This non-randomized prospective cohort study was conducted from May 21 to June 30, 2020, at four majo
Externí odkaz:
https://doaj.org/article/6f0e56e510e141aba25350a63a725290
Autor:
Nashmi Alshammari, Azeez Alzafiri, Abdulrahman Alshammari, Alia Embaireeg, Najat A. Rouheldeen, Mariam Ayed, Sondas Ibrahim Alsharidah, Fatma Alhuraish, Salem Alqahtani, Abdullah Alsaeedi, Farah R. Alshammari, Enas F. Gouda, Reem Ameen, Mohammad A. Aljasmi, Maitham Adel, Mohammad Almehanna, Medhat Askar, Husain Awad, Humoud A. Alenezi, Mohammed E. Dawoud, Hussan Arian, Wasel Al-Adsani, Mariam Almelahi
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 103, Iss, Pp 439-446 (2021)
International Journal of Infectious Diseases, Vol 103, Iss, Pp 439-446 (2021)
Highlights • Convalescent plasma is adjunct treatment in COVID-19 moderate and severe disease. • Clinical improvement is noticed in COVID-19 disease after convalescent plasma. • Mortality is significantly reduced after COVID-19 convalescent pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7ffe4bddd44c62c92f9a9c287a7c43
Autor:
Mariam Almelahi, Mohammed E. Dawoud, Abdulrahman Alshammari, Salem Alqahtani, Mariam Ayed, Mohammad Almehanna, Najat A. Rouheldeen, Humoud A. Alenezi, Medhat Askar, Farah R. Alshammari, Reem Ameen, Mohammad A. Aljasmi, Abdullah Alsaeedi, Azeez Alzafiri, Maitham Adel, Enas F. Gouda, Husain Awad, Nashmi Alshammari, Alia Embaireeg, Sondas Ibrahim Alsharidah, Fatma Alhuraish, Wasel Al-Adsani, Hussain Arian
Publikováno v:
SSRN Electronic Journal.
Background: The transfusion of COVID-19 convalescent plasma (CCP) is being considered to improve clinical outcomes in patients with COVID-19 disease. We investigated the effectiveness of CCP therapy in patients withmoderate and severe COVID-19 diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ebb85078bf327aa22f7c1f1ee9efbb2
https://doi.org/10.2139/ssrn.3685932
https://doi.org/10.2139/ssrn.3685932